ARCHIVES

FDA Vs. NCI: Nothing Has Changed; Chabner “Frustrated” By Flutamide Delay

This article is from The Cancer Letter archive.

Vol. 14 No. 41 | October 21, 1988

Download PDF Visit The Full Archive

Related Articles

Study Validates “PEM” Scans As Biopsy Guidance Method

April 29, 2011

Study: Routine CT Not Needed In Detecting DLBCL Remissions

May 31, 2013

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

April 28, 2006

Only 45 CCOPs Likely To Be Funded Unless More Money Is Made Available; ACCC Goes To Congress

March 20, 1987

Hormonal Therapy Improves Prostate Cancer Survival

August 27, 2004

Targeting Men At High Risk Finds More Head & Neck Cancer

September 24, 2010